Focus: Seismic Therapeutic is a public biotech company specializing in bispecific therapeutic antibodies, a next-generation immunology platform with potential to address multiple autoimmune and immune-mediated diseases. Based in Watertown, MA, the company operates at an early clinical stage with a focused pipeline.
Profile data last refreshed 29m ago · AI intelligence enriched 2w ago
Best suited for early-stage biotech believers with high risk tolerance and a 3–5 year horizon; avoid if you need stability, clear advancement paths, or near-term revenue catalysts.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Seismic Therapeutic
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Seismic Therapeutic's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Recent peer-reviewed publications with author affiliations at this company
Showing 5 of 10 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo